Voloridge Investment Management, LLC Prelude Therapeutics Inc Transaction History

Voloridge Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.0 - $7.55 $46,972 - $88,659	-11,743 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$6.9 - $13.22 $188,169 - $360,522	-27,271 Reduced 69.9%	11,743 $81,000
Q4 2021 Feb 14, 2022	BUY	$11.89 - $31.74 $463,876 - $1.24 Million	39,014 New	39,014 $486,000
Q3 2021 Nov 15, 2021	SELL	$25.78 - $38.65 $394,923 - $592,079	-15,319 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$28.63 - $44.3 $438,582 - $678,631	15,319 New	15,319 $439,000

35.7M

500

300

Ticker PRLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,369,200
Market Cap $48.7M
Description
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.